欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
AT/H/0770/001
药品名称
Pernuvi 50 mg Tabletten
活性成分
vildagliptin 50.0 mg
剂型
Tablet
上市许可持有人
Teva B.V. Swensweg 5 2031GA Harlem, Netherlands
参考成员国 - 产品名称
Austria (AT)
Pernuvi 50 mg Tabletten
互认成员国 - 产品名称
许可日期
2019/01/21
最近更新日期
2023/08/29
药物ATC编码
A10BH02 vildagliptin
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
PAR
|
updated PAR_AT_H_0768_0770_001_DC
Date of last change:2023/08/30
Final PL
|
final_common_PL_AT_H_0770_001_IB_009_clean
Date of last change:2023/05/08
Final SPC
|
final_common_SmPC_AT_H_0770_001_IB_009_clean
Date of last change:2023/05/08
Final Labelling
|
final_common_LAB_AT_H_0770_IB_006_G_clean
Date of last change:2022/06/02
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase